← Open Payments lookup

RACHEL STEIN: Open Payments

NPI 1255056982 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$737 in 22 payments from 9 companies in 2025. Trend: 2023 $548 · 2024 $776 · 2025 $737

Food & beverage: $737
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$165
Neurocrine BioSciences, Inc.3$146
E.R. Squibb & Sons, L.L.C.2$112
Janssen Pharmaceuticals, Inc2$86
Teva Pharmaceuticals USA, Inc.4$81
ABBVIE INC.3$64
Vanda Pharmaceuticals Inc.2$42
Alkermes, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: INGREZZA, REXULTI, COBENFY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, HETLIOZ, VRAYLAR, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.